Publications by authors named "Masuhiro Yoshitake"

Claim this Profile
D
Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
Yongge Liu, Makoto Matsumoto, Hidekaza Ishida, Kinue Ohguro, Masuhiro Yoshitake

Tuberculosis (Edinb)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilostazol increases tissue blood flow in contracting rabbit gastrocnemius muscle.
Miranda Fong, Masuhiro Yoshitake, Junichi Kambayashi, Yongge Liu

Circ J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Yutaka Matsumoto, Hisao Takizawa, Xiaoqi Gong, Sang Le, Simon Lockyer, Masuhiro Yoshitake

Thromb Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.
Simon Lockyer, Keiji Okuyama, Shahinoor Begum, Sang Le, Bing Sun, Masuhiro Yoshitake

Thromb Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single embryonic stem cell-derived embryoid bodies for gene screening.
Masashi Niimi, Mu-Young Kim, Lian Tao, Hongmei Liu, Xiaoyun Wu, Masuhiro Yoshitake

Biotechniques· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet and antithrombotic activity of cilostazol is potentiated by dipyridamole in rabbits and dissociated from bleeding time prolongation.
Haiquan Li, James Cone, Miranda Fong, Junichi Kambayashi, Masuhiro Yoshitake

Cardiovasc Drugs Ther· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
Yongge Liu, James Cone, Sang N Le, Miranda Fong, Lian Tao, Masuhiro Yoshitake

J Cardiovasc Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilostazol as a unique antithrombotic agent.
Junichi Kambayashi, Yongge Liu, Bing Sun, Yasmin Shakur, Masuhiro Yoshitake

Curr Pharm Des· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of glycoprotein VI in vascular endothelial cells.
Bing Sun, Lian Tao, Shihua Lin, Noel Y Calingasan, Jess Li, Masuhiro Yoshitake

Platelets· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of glycoprotein VI in vascular endothelial cells.
Bing Sun, Lian Tao, Shihua Lin, Noel Y Calingasan, Jess Li, Masuhiro Yoshitake

Platelets· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New mechanism of action for cilostazol: interplay between adenosine and cilostazol in inhibiting platelet activation.
Bing Sun, Sang N Le, Shihua Lin, Miranda Fong, Maurice Guertin, Masuhiro Yoshitake

J Cardiovasc Pharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
Yasmin Shakur, Miranda Fong, James Hensley, James Cone, Matthew A Movsesian, Masuhiro Yoshitake

Cardiovasc Drugs Ther· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis